Nosocomial Infection Impact Factor
Nosocomial infections, also known as hospital-acquired infections, are newly acquired, contracting infections in a hospital setting. Transmission typically occurs by
health-care staff , patients, hospital equipment, or procedure. The blood stream, lungs, urinary tract, and surgical wounds are the most common sites of infection. While any bacteria can cause a nosocomial infection, the incidence of multidrug-resistant ( MDR) pathogens that cause hospital-acquired infections is that. This increase can be explained by the indiscriminate use of antibiotics and the lack of hygiene measures, in particular among medical personnel. Multidrug-resistant pathogens commonly seen include methicillin-resistant Staphylococcus aureus (MRSA), bacteria producing an extended-spectrum beta-lactamase (ESBL), and enterococci (VRE) resistant to vancomycin. The antibiotic option for the treatment of infections with these pathogens is dependent on the individual resistance profile and often involves additional strict methods of isolation for the patient.
High Impact List of Articles
-
The importance of social media to clinical practice
B Mesko
Opinion Article: Clinical Practice
-
The importance of social media to clinical practice
B Mesko
Opinion Article: Clinical Practice
-
Epidemiology and management of childhood multidrug-resistant tuberculosis
H Simon Schaaf* and James A Seddon
Review Article: Clinical Practice
-
Epidemiology and management of childhood multidrug-resistant tuberculosis
H Simon Schaaf* and James A Seddon
Review Article: Clinical Practice
-
Fixed-dose combination rosiglitazone/glimepiride in the treatment of Type 2 diabetes mellitus
Giuseppe Derosa, Sibilla AT Salvadeo and Arrigo FG Cicero
Drug Evaluation: Clinical Practice
-
Fixed-dose combination rosiglitazone/glimepiride in the treatment of Type 2 diabetes mellitus
Giuseppe Derosa, Sibilla AT Salvadeo and Arrigo FG Cicero
Drug Evaluation: Clinical Practice
-
Experimental model of reversible myelosuppression caused by shortterm, high-dose oxazolidinone administration
Emily J Hickey, CJ Gill, AS Misura, AF Flattery and GK Abruzzo
Research Article: Clinical Practice
-
Experimental model of reversible myelosuppression caused by shortterm, high-dose oxazolidinone administration
Emily J Hickey, CJ Gill, AS Misura, AF Flattery and GK Abruzzo
Research Article: Clinical Practice
-
Recombinant human activated protein C in sepsis: previous concerns and current usage
Michael Haley, Xizhong Cui, Peter C Minneci, Katherine J Deans, Charles Natanson and Peter Q Eichacker
Review Article: Clinical Practice
-
Recombinant human activated protein C in sepsis: previous concerns and current usage
Michael Haley, Xizhong Cui, Peter C Minneci, Katherine J Deans, Charles Natanson and Peter Q Eichacker
Review Article: Clinical Practice
Relevant Topics in Clinical